Epstein-Barr virus-associated lymphoproliferative diseases

Clinical trials for Epstein-Barr virus-associated lymphoproliferative diseases explained in plain language.

Never miss a new study

Get alerted when new Epstein-Barr virus-associated lymphoproliferative diseases trials appear

Sign up with your email to follow new studies for Epstein-Barr virus-associated lymphoproliferative diseases, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Cord blood transplant offers new hope for rare EBV diseases

Disease control Recruiting now

This study tests whether a transplant of donated umbilical cord blood can help people aged 14 to 80 with serious diseases caused by the Epstein-Barr virus (EBV), such as certain lymphomas or chronic active EBV infection. The goal is to control the disease and improve survival, bu…

Matched conditions: EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISEASES

Phase 2 • Sponsor: Fudan University • Aim: Disease control

Last updated Jun 27, 2026 09:01 UTC

Epstein-Barr virus-associated lymphoproliferative diseases

Get alerted when new Epstein-Barr virus-associated lymphoproliferative diseases trials appear

Cord blood transplant offers new hope for rare EBV diseases